0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Graft versus host disease (GVHD)- Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-152
Home | Market Reports | Health
Graft versus host disease Epidemiology Forecast to 2028

Graft versus host disease (GVHD)- Epidemiology Forecast to 2028

Code: DELV-Epid-152
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Graft versus host disease (GVHD) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Graft versus host disease (GVHD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Graft versus host disease (GVHD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Graft versus host disease (GVHD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Graft versus host disease (GVHD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Graft versus host disease (GVHD) scenario.

Graft versus host disease (GVHD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Graft versus host disease (GVHD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Graft versus host disease (GVHD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Graft versus host disease (GVHD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Graft versus host disease (GVHD)

Key assessments
• Patient Segmentation in Graft versus host disease (GVHD)
• Graft versus host disease (GVHD) Risk & Burden
• Factors driving growth in a specific Graft versus host disease (GVHD) patient population

1. Report Introduction
2. Graft versus host disease (GVHD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Graft versus host disease (GVHD) in 2016
2.2. Patient Share Distribution of Graft versus host disease (GVHD) in 2028
3. Disease Background and Overview: Graft versus host disease (GVHD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Graft versus host disease (GVHD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Graft versus host disease (GVHD) in 7MM – By Countries
5. Epidemiology of Graft versus host disease (GVHD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.1.3. Sub-Type Specific cases of the Graft versus host disease (GVHD) *
5.1.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.1.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.4.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.4.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.4.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.5.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.5.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.5.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.6.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.6.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.6.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.7.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.7.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.7.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.8.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.8.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.8.5. Diagnosed Cases of the Graft versus host disease (GVHD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD)
5.9.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)*
5.9.4. Sex- Specific Cases of the Graft versus host disease (GVHD)*
5.9.5. Diagnosed Cases of the Graft versus host disease (GVHD)
6. Unmet Needs of the Graft versus host disease (GVHD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Graft versus host disease (GVHD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Graft versus host disease (GVHD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Graft versus host disease (GVHD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Graft versus host disease (GVHD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Graft versus host disease (GVHD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Graft versus host disease (GVHD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Graft versus host disease (GVHD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Graft versus host disease (GVHD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Graft versus host disease (GVHD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Graft versus host disease (GVHD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Graft versus host disease (GVHD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Graft versus host disease (GVHD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Graft versus host disease (GVHD) in Japan (2016-2028)

Listof figures :

Figure 1: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Graft versus host disease (GVHD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Graft versus host disease (GVHD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Graft versus host disease (GVHD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Graft versus host disease (GVHD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Graft versus host disease (GVHD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Graft versus host disease (GVHD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Graft versus host disease (GVHD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Graft versus host disease (GVHD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Graft versus host disease (GVHD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Graft versus host disease (GVHD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Graft versus host disease (GVHD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Graft versus host disease (GVHD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Graft versus host disease (GVHD) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Glottic Cancer Treatment Market Size Status and Forecast 2021 2027
Global Glottic Cancer Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25Y923
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Hypoactive Sexual Desire Disorder HSDD Treatment Market Size Status and Forecast 2021 2027
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18V1462
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Inflammatory Bowel Disease Market Size Status and Forecast 2021 2027
Global Inflammatory Bowel Disease Market Size, Status and Forecast 2021-2027

The global Inflammatory Bowel Disease market size is projected to reach US 16820 million by 2027 from US 12800 million in 2020 at a CAGR of 3.5 during 20212027.Global Inflammatory Bowel Disease Market Size Status and Forecast 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-39W5849
Sun Jul 18 00:00:00 UTC 2021

Add to Cart